Scientific Programme 2024

Wednesday 17th January 2024

SESSION: EVOLVING DONOR PRESERVATION TECHNIQUES

Moderator: Michiel Erasmus + one young investigator

(20 min talk and 10 min Q&A)

16.00–16.30

DBD heart trial XVIVO,

Filip Rega
Leuven, Belgium

16.30–17.00

EVLP on DCD lungs

Eduoard Sage
Suresnes, France

17.00–17.30

European data on SherpaPak

Andreas Zuckermann
Vienna, Austria

17.30–18.00

Coffee Break


Session - Fascinating Failures and Surprising Successes

Moderator: Katrijn Jansen + one young investigator

(10 min talk and 5 min Q&A)

18.00–18.15
How to mess up CMV prophylaxis

Erik Verschuuren
Groningen, The Netherlands

18.15–18.30
Isolated heart transplant in child with CHD related PH

Mohamed Nassar
Newcastle upon Tyne, UK

18.30–18.45
The dratted fungus in a heart-lung transplant recipient

Dr Anja Roden
Rochester Minnesota, USA

18.45–19.00
From Heaven to Hell – primary cardiac intimal sarcoma

Ivan Knezevic
Ljubljana, Slovenia

19.00–19.15
Fatal Airway complication after Lung transplantation

Arve Sundset
Oslo, Norway

19.15–19.30
A big hole in a small patient: Iatrogenic esophageal perforation after bilateral lobar lung transplantation

Martin Silverborn
Gothenburg, Sweden

Thursday 18th January 2024

SESSION: NEW WAYS OF MONITORING GRAFT FUNCTION

Moderator: Göran Dellgren + young investigator

(15 min talk and 5 min Q&A)

16.00–16.20

Airway oscillometry parameters in baseline lung allograft dysfunction – multicentre study

Greg Snell,
Melbourne, Australia

16.20–16.40

Cell-free DNA as biomarker after heart and lung transplantation

Jens Böhmer,
Gothenburg, Sweden

16.40–17.00

Multiomics signatures that precede CLAD in lung transplantation

Greg Westall,
Melbourne, Australia

17.00–17.15

Business Meeting

17.15–17.30

Coffee break

SESSION: MECHANICAL CIRCULATORY SUPPORT FROM CHILD TO ADULT

Clive Lewis and young investigator

(15 min talk and 5 min Q&A)

17.30–17.50

ECMO and alternatives as bridge to transplant in the paediatric population

Judit Llevadias,
Newcastle upon Tyne, UK

17.50–18.10

Short term mechanical circulatory support in adults – whats the current practice

Hassiba Smail,
Cambridge, UK

18.10–18.30

Introduction of EXCOR Revive and the EXCOR venous cannula in the failing Fontan

Joeri van Puyvelde
Leuven, Belgium

18.30–18.50

Present State and Upcoming Developments of LVAD Therapy

Stephan Schueler,
Newcastle upon Tyne, UK

18.50–19.00

Coffee break

19.00–19.30

Session: WERNER ZUBER MEMORIAL LECTURE

19.00–19.30
Deepsea Diving

Jan Risberg,
Bergen, Norway

Friday 19st January 2024

SESSION: CURRENT AND FUTURE CHALLENGES IN PULMONARY HYPERTENSION AND TRANSPLANTATION

Michael Perch + young investigator

(20 min talk and 10 min Q&A)

16.00–16.30

Differentiation of unclear dyspnea and pulmonary hypertension – who to treat and not to treat?

Göran Radegran, Lund, Sweden

16.30–17.00

Desensitization in heart and lung transplantation- where do we stand today?

John Scott,
Rochester Minnesota, USA

17.00–17.30

Park and preserve of donor lungs

Niels van der Kaaij
Utrecht, The Netherlands

17.30–17.45

Coffee break

17.45–18.15

Moderator: Hans Eiskjaer

PRO-CON DEBATE
Heart and lungs from COVID positive donor - To use or not to use?

Pro: Erik Verschuuren,
Groningen, The Netherlands

Con: Margaret Hannan,
Dublin, Ireland

18.15–18.30

Coffee break

18.30–19.30

Session: Young Investigators Award

(8 min. talk and 2 min Q&A)

18.30–18.40
Pregnancy after lung transplantation in the Netherlands

Jildau Meinderts
Groningen, The Netherlands

18.40–18.50
Immunogenic changes after peri-transplant desensitization in patients with preformed donor specific antibodies in lung transplantation: a ten-year single centre experience

Philipp Wand
Hannover, Germany

18.50–19.00
Paediatric lung transplantation in the Netherlands: a 27-year single centre experience

Anton Van As
Groningen, The Netherlands

19.00–19.10
Targeting sphingosine-1-phosphate receptor-1 protects vascular endothelial integrity during human ex vivo lung perfusion

Jenny Gilmour
Newcastle upon Tyne, UK

19.10–19.20
Microdialysis used to measure myocardial ischemic metabolites in both cardiac ventricles in the DCD donor during NRP followed by static cold storage and subsequent heart transplantation.

Maja Thomassen
Aarhus, Denmark

19.20–19.30
Preserving mitochondrial function in donor heart preservation with sodium thiosulfate: a pre-clinical ovine model.

Imran Ertugrul
Groningen, The Netherlands